Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antiphospholipid syndrome

A Muir1

  • 1Department of Medicine, Ninewells Hospital and Medical School, Dundee.

Scottish Medical Journal
|July 31, 1998
PubMed
Summary
This summary is machine-generated.

Antiphospholipid syndrome is an acquired disorder causing blood clots. Research is improving understanding and diagnostic tests, with future trials needed to optimize treatment for positive patients without prior events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of the shattered pellet injection system for ASDEX Upgrade.

The Review of scientific instruments·2023
Same author

Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

The European physical journal. C, Particles and fields·2022
Same author

Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

The European physical journal. C, Particles and fields·2021
Same author

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Molecular genetics and metabolism·2021
Same author

Development and internal validation of clinical prediction models for outcomes of complicated intra-abdominal infection.

The British journal of surgery·2021
Same author

First Results from the DEAP-3600 Dark Matter Search with Argon at SNOLAB.

Physical review letters·2018
Same journal

Association of inflammation with sex hormones and vitamin D in women: Findings from NHANES (2021-2023).

Scottish medical journal·2026
Same journal

The future of large language models in clinical and academic medicine.

Scottish medical journal·2026
Same journal

ICDMS: Integrating multimodal data for intelligent clinical decision-making in healthcare: Current trends and future directions.

Scottish medical journal·2026
Same journal

Evaluation of large language models with clinical guidance for vetting outpatient magnetic resonance imaging lumbar spine referrals.

Scottish medical journal·2026
Same journal

Improving access and reducing patient travel burden through telehealth: A quality improvement report from NHS Scotland.

Scottish medical journal·2026
Same journal

Scottish Cardiac Society 34th Annual General Meeting Thursday 2 & Friday 3 October 2025.

Scottish medical journal·2026
See all related articles

Area of Science:

  • Hematology
  • Immunology
  • Vascular Medicine

Background:

  • Antiphospholipid syndrome (APS) is a recognized acquired prothrombotic disorder.
  • Current understanding addresses the in vitro anticoagulation and in vivo prothrombotic paradox in APS.
  • Advances in understanding APS are ongoing.

Purpose of the Study:

  • To highlight current understanding of antiphospholipid syndrome.
  • To emphasize the need for improved diagnostic assays.
  • To call for further research into optimal treatment strategies.

Main Methods:

  • Review of current knowledge on antiphospholipid syndrome.
  • Discussion of diagnostic challenges and future assay development.
  • Identification of research gaps in treatment optimization.

Related Experiment Videos

Main Results:

  • Antiphospholipid syndrome is a well-established prothrombotic condition.
  • Understanding of the in vitro/in vivo paradox is advancing.
  • Improved diagnostic assays for APS are anticipated.

Conclusions:

  • Further advancements in antiphospholipid syndrome diagnostics are expected.
  • Large-scale, controlled trials are necessary to define optimal treatment for APS patients.
  • Research is crucial for managing patients testing positive for APS but without thrombotic events.